The controlling shareholder of Tianjin Pharmaceutical Da Ren Tang Group Corporation (600329.SH) plans to increase its holdings of the company's S-shares by 14.30 million to 28.59 million yuan.

Tianjin Pharmaceutical Da Ren Tang Group Corporation (600329.SH) announced that one of the company's major shareholders, Jing Yao International Limited, collectively purchased 82,200 shares of the company's S stock through the Singapore Exchange trading system on February 4, 2026, accounting for 0.0107% of the total share capital of the company. Based on confidence in the future development prospects of Tianjin Pharmaceutical Da Ren Tang Group Corporation and recognition of its long-term investment value, Jing Yao International Limited plans to increase its stake in the company's S stock through the Singapore Exchange trading system in the next 6 months (starting from the date of this increase), with the cumulative increase not exceeding 1% of the total share capital (including the 0.0107% shares already increased). The price condition for increasing the S stock is not higher than $4 per share (including this amount); the amount range for increasing shares is not less than RMB 14.3 million (including this amount), not more than RMB 28.59 million (including this amount), including the amount of the shares already increased.